Subir Kohli is Co-founder and CEO of Celix Pharma. He has over 18 years’ experience in the European generic pharmaceutical industry, across product development, portfolio management, strategic business development, and commercial operations. Prior to founding Celix Pharma, he was Vice President, Head of Sales & Marketing for Dr. Reddy’s European Generics business, in addition to his role as Managing Director of Dr. Reddy’s (UK) Ltd. In his last role, he was instrumental in leading Dr. Reddy’s geographical expansion in Western Europe through new affiliates in France, Italy and Spain. As Managing Director for UK, he reshaped the UK subsidiary by adding two new channels of business - Specialty hospital and Branded generics. His vision for Celix is to build an organization offering high quality and value-added generic products to patients and healthcare providers. Subir has an MBA from the Indian Institute of Management (IIM), Bangalore and a B. Tech from the Indian Institute of Technology (IIT), Kanpur.